2021
DOI: 10.3390/genes12081184
|View full text |Cite
|
Sign up to set email alerts
|

MiRNA Let-7a and Let-7d Are Induced by Globotriaosylceramide via NF-kB Activation in Fabry Disease

Abstract: Background: Fabry disease is a hereditary genetic defect resulting in reduced activity of the enzyme α-galactosidase-A and the accumulation of globotriaosylceramide (Gb3) in body fluids and cells. Gb3 accumulation was especially reported for the vascular endothelium in several organs. Methods: Three Fabry disease patients were screened using a micro-RNA screen. An in vitro approach in human endothelial cells was used to determine miRNA regulation by Gb3. Results: In a micro-RNA screen of three Fabry patients u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Alterations in over 100 circulating miRNAs were identified in blood samples from FD patients in treatment with ERT compared with untreated patients (Xiao et al, 2019). Increased expression of miRNA miR-29a-3p and miR-200a-3p were detected in urinary extracellular vesicles isolated from patients with FD nephropathy (Levstek et al, 2021) which associates with the progression of kidney damage (Maier et al, 2021); miR-let-7a and let-7d were significantly increased in FD after therapy and have been suggested as potential markers for enzyme activity and inflammation in FD patients (Maier et al, 2021). These data point at miRNA profiling as a powerful diagnostic tool of FD progression and drug testing, as well as indicators of the development of specific FD phenotypes.…”
Section: Introductionmentioning
confidence: 99%
“…Alterations in over 100 circulating miRNAs were identified in blood samples from FD patients in treatment with ERT compared with untreated patients (Xiao et al, 2019). Increased expression of miRNA miR-29a-3p and miR-200a-3p were detected in urinary extracellular vesicles isolated from patients with FD nephropathy (Levstek et al, 2021) which associates with the progression of kidney damage (Maier et al, 2021); miR-let-7a and let-7d were significantly increased in FD after therapy and have been suggested as potential markers for enzyme activity and inflammation in FD patients (Maier et al, 2021). These data point at miRNA profiling as a powerful diagnostic tool of FD progression and drug testing, as well as indicators of the development of specific FD phenotypes.…”
Section: Introductionmentioning
confidence: 99%
“…At a cellular level, GB3 accumulation has been linked to inflammation, ROS production, NFκB activation, leading to cell death as well as sclerosis, fibrosis, etc. ( 6 9 ). GB3 accumulation has also been observed in the testis ( 10 ).…”
Section: Introductionmentioning
confidence: 99%
“… 23 , 24 Additionally, miR-184, let-7a, and let-7d have been reported to be beneficial in diagnosing and treating Fabry disease, a hereditary cerebral small vessel disease. 25 , 26 Nevertheless, the study of circulating exosomal miRNAs in CSVD is still in its infancy. In the few studies published so far, exosomal miRNA-17 family and miR-223-3p were proved to be closely related to the initiation and development of CSVD.…”
Section: Discussionmentioning
confidence: 99%
“…23,24 Additionally, miR-184, let-7a, and let-7d have been reported to be beneficial in diagnosing and treating Fabry disease, a hereditary cerebral small vessel disease. 25,26 Nevertheless, the study of circulating exosomal miRNAs in…”
Section: Discussionmentioning
confidence: 99%